CompletedNot applicableNCT00175838

Primary Thrombocythaemia 1 Trial

Studying Essential thrombocythemia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Cambridge
Principal Investigator
Anthony R Green, Prof
Addenbrooke's Hospital and University of Cambridge
Intervention
Hydroxyurea(drug)
Enrollment
1398 enrolled
Eligibility
40-59 years · All sexes
Timeline
1997 – 2016

Study locations (1)

Collaborators

Cambridge University Hospitals NHS Foundation Trust · Institute of Cancer Research, United Kingdom

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00175838 on ClinicalTrials.gov

Other trials for Essential thrombocythemia

Additional recruiting or active studies for the same condition.

See all trials for Essential thrombocythemia →

← Back to all trials